Are Higher Tax Rates Actually Bad for Stocks?
President Biden is proposing higher tax rates for the rich, which caused a brief sell-off last week. But are tax hikes truly bad for stocks?
Read More
President Biden is proposing higher tax rates for the rich, which caused a brief sell-off last week. But are tax hikes truly bad for stocks?
Read More
Analysts are forecasting higher earnings for this medical device company, which has recently announced to acquisitions, boosting its product offerings.
Read More
While small caps as a group lagged behind the broad market in 2017, these three small-cap sectors have plenty of momentum and are poised for more in 2018.
Read More
This health insurer beat Wall Street’s estimates by $0.11 last quarter.
Read More
Healthcare has been the best stock market sector of 2017, with small caps leading the way. Here are three small-cap healthcare stocks I like best.
Read More
Wall Street believes this healthcare stock is going to produce double-digit growth over the next five years. The shares were recently upgraded by Morgan Stanley to ‘Overweight’.
Read More
Despite what Mitch McConnell said this week, U.S. health insurers are thriving financially - and so are a few health insurance stocks.
Read More
The big news this week was the failure of Republicans to move forward on repeal and replace of the Affordable Care Act (ACA), also known as Obamacare.
Even though President Trump came out on Wednesday to try and rally the troops, it seems far likely...
Read More
Health insurance stocks got roughed up after the Trumpcare bill failed in the Senate. And that creates a great buying opportunity in these three stocks.
Read More
A recent Reuters survey of 24 brokerage companies showed strong support for the shares of this medical products company, with 79% of analysts giving it a ‘Buy’ rating, and 21% rated the shares a ‘hold.’
Read More
House Republicans introduced an ObamaCare reform bill on Tuesday, extending a rally in health insurance stocks that started when Donald Trump was elected.
Read More
I expect the Trump effect to favor value stocks at the detriment of growth stocks in 2017. If stocks continue to rise next year, albeit at a slower pace, the advance will certainly spread to other sectors. Technology stocks, except those with sky-high should...
Read More
The top five holdings in this biotech fund are: Gilead Sciences Inc (GILD, 10.30% of assets); Celgene (CELG, 7.58%); Incyte (INCY, 5.79%); Biogen (BIIB, 5.36%) and Vertex Pharmaceuticals (VRTX, 4.59%).
Tekla Life Sciences Investors (HQL)
From Sound Advice
During his campaign, Trump promised to repeal the Care...
Read More
Did you have some serious losses in 2015? If so, figure out where you went wrong and try your best not to make the same mistakes in 2016. Investing is a constant learning experience. We all need to review our past performance, and or...
Read More
This business process management company beat analysts’ estimates by $0.04 last quarter. Wall Street is forecasting that the company will grow 45% this quarter and 21% in 2017.
MAXIMUS (MMS) From Hendershot Investments
MAXIMUS (MMS) delivers innovative business process management and technology solutions that contribute improved...
Read More
Boosted by a healthier employment picture, this payment processor is growing at double-digit rates. The current dividend yield is 2.40%, paid quarterly.
Automatic Data Processing (ADP) From Hendershot Investments
Automatic Data Processing (ADP), a pioneer in business process outsourcing, is a leading provider of technology-enabled capital...
Read More
Three analysts have increased their EPS estimates for this healthcare outsourcer in the past 30 days. The median price target is $49.38 per share.
Team Health Holdings (TMH)From Cabot Benjamin Graham Value Investor Enterprising Model
Team Health Holdings (TMH) is a provider of outsourced healthcare staffing...
Read More
How do you find growth companies that pay dividends? Using the Cabot resources, there are two excellent ways. One is to refer to Cabot Dividend Investor, which recommends three specific classes of stocks for its readers: High Yield, Dividend Growth and Income...
Read More
Our first recommendation today is a company that IPO’d in July 2014. Institutions have recently purchased almost 7 million shares, seven out of eight analysts have a “buy” rating on the stock, and three have increased their earnings estimates in the past 30 The...
Read More
What follows just might sound like the craziest thing I’ve ever written. But hear me out if you can—and try to keep an open mind. I’ve been writing about investing and capitalism for the past 29 years, and in that time I’ve a..
Read More